Cargando…
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)
Systemic forms of amyloidosis affecting the heart are mostly light-chain (AL) and transthyretin (ATTR) amyloidoses. The latter is caused by deposition of misfolded transthyretin, either in wild-type (ATTRwt) or mutant (ATTRv) conformation. For diagnostics, specific serum biomarkers and modern non-in...
Autores principales: | Yilmaz, A., Bauersachs, J., Bengel, F., Büchel, R., Kindermann, I., Klingel, K., Knebel, F., Meder, B., Morbach, C., Nagel, E., Schulze-Bahr, E., aus dem Siepen, F., Frey, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055575/ https://www.ncbi.nlm.nih.gov/pubmed/33459839 http://dx.doi.org/10.1007/s00392-020-01799-3 |
Ejemplares similares
-
Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms
por: Korosoglou, Grigorios, et al.
Publicado: (2021) -
Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013) -
Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis
por: Hoerbrand, Isabel A., et al.
Publicado: (2022) -
Thickness of the midventricular left ventricular wall is predictive of survival in different forms of cardiac amyloidosis
por: aus dem Siepen, Fabian, et al.
Publicado: (2013) -
Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis
por: Hein, Selina J, et al.
Publicado: (2021)